<DOC>
	<DOCNO>NCT02958085</DOCNO>
	<brief_summary>This trial conduct The United States America . The aim trial investigate Safety , Tolerability , Pharmacokinetics ( exposure trial drug body ) Pharmacodynamics ( effect investigate drug body ) Multiple Dosing NNC0174-0833 Subjects Obesity Overweight .</brief_summary>
	<brief_title>Investigation Safety , Tolerability , Pharmacokinetics Pharmacodynamics Multiple Dosing NNC0174-0833 Subjects With Obesity Overweight</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Nutrition Disorders</mesh_term>
	<criteria>Male female nonchildbearing potential ( NCBP ) , age 2255 year ( inclusive ) time sign informed consent Body mass index ( BMI ) 25.0 39.9 kg/m^2 ( inclusive ) screen . Overweight due excess adipose tissue , judge investigator History presence clinically relevant respiratory , metabolic , renal , hepatic , gastrointestinal , endocrinological , haematological , dermatological , venereal , neurological , major disorder include sleep apnoea excessive sleepiness might require medical attention History presence cardiovascular disease include stable unstable angina , myocardial infarction , transient ischaemic attack , stroke , cardiac decompensation , heart failure History presence disease associate impaired calcium homeostasis and/or increase bone turnover ( e.g . PagetÂ´s disease , osteoporosis ) Male subject surgically sterilise ( vasectomy ) sexually active female partner ( ) use highly effective method contraception ( condom spermicide ) combine highly effective method contraception nonpregnant female partner ( ) childbearing potential ( Pearl Index 1 % , implant , injectables , oral contraceptive , intrauterine device , diaphragm cervical cap+spermicide ) , and/or intend donate sperm period screen 3 month follow administration last dose investigational medical product</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>